Cardiac Precision Medicine represents a cutting-edge approach that tailors cardiovascular care to the unique genetic, molecular, and clinical characteristics of individual patients. By delving into the intricate details of an individual's genetic makeup, lifestyle, and environmental factors, Cardiac Precision Medicine aims to create personalized treatment strategies for cardiovascular conditions. This innovative field harnesses the power of advanced technologies, such as genomics and data analytics, to identify specific genetic variations and biomarkers associated with cardiovascular diseases. The ultimate goal is to enhance the accuracy of diagnosis, predict the risk of cardiovascular events, and optimize treatment outcomes. Cardiac Precision Medicine heralds a new era in cardiovascular healthcare, paving the way for more targeted and effective interventions tailored to the specific needs of each patient.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India